
Mounjaro 7.5mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Mounjaro 7.5mg Injection
contains Tirzepatide 7.5mg in a once-weekly KwikPen, representing an intermediate escalation dose between 5mg and 10mg. At this level, both GIP and GLP-1 receptor activation is robust, producing advanced appetite suppression, accelerated weight loss, and significant cardiometabolic improvements.
Benefits:
- Robust dual GIP/GLP-1 activation for accelerated weight reduction
- Continued HbA1c improvement beyond 5mg
- Substantial visceral fat reduction with associated blood pressure benefits
- Well-tolerated step between 5mg and 10mg for patients who need gradual escalation
- Clinically validated dose in SURPASS and SURMOUNT trial programmes
How It Works:
At 7.5mg, tirzepatide simultaneously engages GIP and GLP-1 receptors with increasing potency. Adipocyte GIP signalling further reduces fat accumulation and improves adipokine profiles. Hypothalamic and brainstem GLP-1 signalling produces marked hunger suppression. The combined effect drives a caloric deficit sufficient for accelerated body weight reduction and progressive improvement in insulin sensitivity and lipid metabolism.
Dosage and Administration:
Inject 7.5mg subcutaneously once weekly after 4 weeks on 5mg. Administer into the abdomen, thigh, or outer upper arm at any time of day. Rotate injection sites. Some patients may be maintained at 7.5mg as their target dose; others will escalate to 10mg after 4 weeks.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, decreased appetite, abdominal pain. Uncommon: headache, fatigue, dizziness, elevated resting heart rate. Serious: acute pancreatitis, cholelithiasis, acute kidney injury, worsening diabetic retinopathy.
Precautions:
Contraindicated in history of medullary thyroid carcinoma or MEN2. Ensure adequate caloric and protein intake to prevent excessive lean mass loss. Gallbladder monitoring recommended given rapid weight loss at this dose level.
Mounjaro Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 2.5mg | Lower strength option | 4β8 wks | Weekly | View β |
| 5mg | Standard strength option | 4β8 wks | Weekly | View β |
| 7.5mg | Popular strength option | 4β8 wks | Weekly | Current |
| 10mg | Popular strength option | 4β8 wks | Weekly | View β |
| 12.5mg | Higher strength option | 4β8 wks | Weekly | View β |
| 15mg | Maximum strength variant | 4β8 wks | Weekly | View β |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Mounjaro 7.5mg used for?
Mounjaro 7.5mg is a dose escalation step in tirzepatide therapy, used for 4 weeks before advancing to 10mg. It delivers meaningful weight loss and glycaemic benefit and may serve as a maintenance dose for patients who meet their goals at this level.
Q2: Is 7.5mg considered a maintenance dose for Mounjaro?
For some patients, particularly those who achieve satisfactory weight loss and glycaemic control at 7.5mg, the prescriber may choose to maintain this dose rather than escalate further. The target dose is individualised.
Q3: How much weight loss is expected at Mounjaro 7.5mg?
In the SURMOUNT-1 trial, participants achieving steady-state tirzepatide doses in the 7.5β10mg range lost approximately 17β19% of body weight over 72 weeks with lifestyle intervention.
Q4: Can I take Mounjaro 7.5mg with insulin glargine?
Yes. Tirzepatide is studied in combination with basal insulin. When added to insulin, significant hypoglycaemia risk reduction is possible β many patients can reduce or eliminate insulin. Close blood glucose monitoring is essential.
Q5: Do the GI side effects get better at higher doses?
Side effects typically peak during dose escalation and improve as the body adapts. At 7.5mg, most patients who tolerated 5mg well experience only mild ongoing nausea that diminishes within 2β4 weeks.
Q6: Why is the Mounjaro escalation schedule slower than Wegovy?
Both programmes use 4-week escalation steps. Mounjaro uses increments of 2.5mg at each step, while Wegovy's increments vary. Both are designed to minimise GI adverse effects; neither should be rushed.
Q7: Can Mounjaro 7.5mg improve sleep apnoea?
Yes. Significant weight loss from Mounjaro substantially reduces severity of obstructive sleep apnoea. The SURMOUNT-OSA trial specifically demonstrated this benefit, with semaglutide-naΓ―ve patients showing dramatic reductions in apnoea-hypopnoea index scores.
Q8: What should I eat on Mounjaro 7.5mg?
A reduced-calorie diet rich in lean protein, vegetables, and fibre is recommended. Adequate protein (1.2β1.6 g/kg ideal body weight) is important to preserve lean muscle mass during rapid weight loss. Avoid large fatty meals that worsen nausea.
Q9: Can I stop Mounjaro 7.5mg if I feel I've lost enough weight?
Discuss any plans to stop with your prescriber. Weight typically returns after stopping. If you wish to discontinue, your prescriber may taper the dose rather than stopping abruptly, and will help you plan a maintenance strategy.
Q10: Is Mounjaro 7.5mg safe with cholesterol-lowering medications?
No clinically significant interactions are expected between tirzepatide and statins, ezetimibe, or fibrates. As weight loss progresses, lipid levels often improve and statin doses may be able to be reduced by your prescriber.
Customer Reviews
Metro Hospital Pharmacy
UK Β· 2 weeks ago
βReliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.β
Global Meds Supply
Germany Β· 6 weeks ago
βOrdering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.β
Thomas B.
Australia Β· 4 months ago
βLegitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.β
Robert Chen
Canada Β· 1 month ago
βVery satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.β
Dr. Emily Parker
UK Β· 2 months ago
βImpressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.β
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.






